Seol-hee Kang

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing's syndrome.

Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing's syndrome.

Journal: American journal of physiology. Endocrinology and metabolism
Published: September 21, 2017

Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome.

Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: March 29, 2017

Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.

Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.

Journal: American journal of physiology. Endocrinology and metabolism
Published: November 01, 2016

Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression.

Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 16, 2016

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: March 18, 2016

Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).

Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).

Journal: Clinical and experimental pharmacology & physiology
Published: October 14, 2015

Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor.

Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor.

Journal: PloS one
Published: June 09, 2015

Combined oral contraceptive synergistically activates mineralocorticoid receptor through histone code modifications.

Combined oral contraceptive synergistically activates mineralocorticoid receptor through histone code modifications.

Journal: European journal of pharmacology
Published: May 08, 2015

Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.

Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.

Journal: Molecular pharmacology
Published: February 11, 2015

Influence of surface characteristics on the adhesion of Candida albicans to various denture lining materials.

Influence of surface characteristics on the adhesion of Candida albicans to various denture lining materials.

Journal: Acta odontologica Scandinavica
Published: March 21, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026